content provided by Cerner Multum, Inc.
| Pronunciation: | ESS troe pih pate |
| Brand: | Ogen 0.625 (estropipate 0.75 mg), Ogen 1.25 (estropipate 1.5 mg), Ogen 2.5 (estropipate 3 mg), Ortho-Est |
What is the most important information I should know about estropipate?
Estropipate increases the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus. Taking progestins, another hormone drug, with estropipate lowers the risk of developing this condition. Therefore, if your uterus has not been removed, your doctor may prescribe a progestin for you to take together with the estrogen. Visit your doctor regularly and report any unusual vaginal bleeding right away.
Treatment with estrogens long-term may increase the risk of stroke. Because of this risk, you should contact your doctor or healthcare provider to discuss your individual risks and benefits before taking an estrogen long-term. You should also talk to your doctor or healthcare provider on a regular basis (for example, every 3-6 months) about whether you should continue this treatment.
Have yearly physical exams and examine your breasts for lumps on a monthly basis while taking estropipate.
 |
Do not take estropipate if you are pregnant. |
Print This
| Last updated: | November 16, 2004 |
|---|
© 2007, Cerner Multum, INC. Version: 5.02.
This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, Use of Content Agreement and AOL Body Advertising Policy. Read more about our content partners.
